Prevention of Type 2 Diabetes and Its Complications in Developing Countries: A Review

BackgroundType 2 diabetes mellitus (T2DM) is a significant global public health problem affecting more than 285 million people worldwide. Over 70% of those with T2DM live in developing countries, and this proportion is increasing annually. Evidence suggests that lifestyle and other nonpharmacological interventions can delay and even prevent the development of T2DM and its complications; however, to date, programs that have been specifically adapted to the needs and circumstances of developing countries have not been well developed or evaluated.PurposeThe purpose of this article is to review published studies that evaluate lifestyle and other non-pharmacological interventions aimed at preventing T2DM and its complications in developing countries.MethodsWe undertook an electronic search of MEDLINE, PubMed, and EMBASE with the English language restriction and published until 30 September 2009.ResultsNine relevant publications from seven studies were identified. The reported interventions predominantly used counseling and educational methods to improve diet and physical activity levels. Each intervention was found to be effective in reducing the risk of developing T2DM in people with impaired glucose tolerance, and improving glycemic control in people with T2DM.ConclusionsThe current evidence concerning the prevention of T2DM and its complications in developing countries has shown reasonably consistent and positive results; however, the small number of studies creates some significant limitations. More research is needed to evaluate the benefits of low-cost screening tools, as well as the efficacy, cost-effectiveness, and sustainability of culturally appropriate interventions in such countries.

[1]  Kate Lorig,et al.  Community-Based Peer-Led Diabetes Self-management , 2009, The Diabetes educator.

[2]  P Zimmet,et al.  International Diabetes Federation: a consensus on Type 2 diabetes prevention , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[3]  A M Albisser,et al.  An Electronic Case Manager for Diabetes Control , 1998, Diabetes Care.

[4]  Standards of Medical Care for Patients With Diabetes Mellitus , 1998, Diabetes Care.

[5]  Ping Zhang,et al.  Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. , 2003, Diabetes care.

[6]  K. Eriksson,et al.  Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study , 1991, Diabetologia.

[7]  M. Heisler,et al.  Different models to mobilize peer support to improve diabetes self-management and clinical outcomes: evidence, logistics, evaluation considerations and needs for future research. , 2010, Family practice.

[8]  K. Lorig,et al.  Spanish Diabetes Self-Management With and Without Automated Telephone Reinforcement , 2008, Diabetes Care.

[9]  J. Piette,et al.  Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. , 2001, Diabetes care.

[10]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[11]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[12]  C. Snehalatha,et al.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.

[13]  R. E. Riley,et al.  An integrated intervention program to control diabetes in overweight Chinese women and men with type 2 diabetes. , 2008, Asia Pacific journal of clinical nutrition.

[14]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[15]  B. Chogtu,et al.  Impact of glitazones on metabolic and haemodynamic parameters in patients with type 2 diabetes mellitus. , 2009, Singapore medical journal.

[16]  Nicola J Cooper,et al.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[17]  S. Kumanyika,et al.  A Randomized Controlled Trial of Weight Reduction and Exercise for Diabetes Management in Older African-American Subjects , 1997, Diabetes Care.

[18]  Teven,et al.  EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .

[19]  Jaakko Tuomilehto,et al.  The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.

[20]  G. Roglić,et al.  Mortality attributable to diabetes: estimates for the year 2010. , 2010, Diabetes research and clinical practice.

[21]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[22]  N. Unwin,et al.  Diabetes in sub-Saharan Africa. , 2001, Advances in experimental medicine and biology.

[23]  P. Zimmet,et al.  Diagnosis and classification of diabetes mellitus , 2002 .

[24]  T. Valle,et al.  The Finnish Diabetes Prevention Study , 2000, British Journal of Nutrition.

[25]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[26]  Diabetes mellitus. Report of a WHO Study Group. , 1985, World Health Organization technical report series.

[27]  R. Jones,et al.  Primary care research: ends and means. , 2000, Family practice.

[28]  E. Fisher,et al.  Cross-cultural and international adaptation of peer support for diabetes management. , 2010, Family practice.

[29]  Ambady Ramachandran,et al.  Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians , 2007, Diabetes Care.

[30]  J. Chan,et al.  Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. , 1992, BMJ.

[31]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[32]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[33]  Hugh Tunstall-Pedoe,et al.  Preventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization, 2005. pp 200. CHF 30.00. ISBN 92 4 1563001. Also published on http://www.who.int/chp/chronic_disease_report/en/ , 2006 .

[34]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[35]  K. Walker,et al.  National evidence based guideline for the primary prevention of type 2 diabetes , 2009 .

[36]  J. Dora,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[37]  Bo Zhang,et al.  The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study , 2008, The Lancet.

[38]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[39]  S. Griffin,et al.  International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes. , 2010, Diabetes research and clinical practice.

[40]  Gene Feder,et al.  Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[41]  J. Chan,et al.  Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. , 2000, Kidney international.

[42]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[43]  Thodoris D. Karapantsios,et al.  Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007. , 2008, Diabetes Care.

[44]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[45]  R. Ozaki,et al.  Effect of Angiotensin-Converting Enzyme Inhibition on Survival in 3773 Chinese Type 2 Diabetic Patients , 2004, Hypertension.

[46]  Hee-Seung Kim,et al.  Technological intervention for obese patients with type 2 diabetes. , 2008, Applied nursing research : ANR.

[47]  T. Lancet Type 2 diabetes—time to change our approach , 2010, The Lancet.

[48]  E. Villavicencio-Suárez The prevalence of diabetes mellitus. , 1965, Boletin de la Asociacion Medica de Puerto Rico.

[49]  D. Dunstan,et al.  The Independent and Combined Effects of Aerobic Exercise and Dietary Fish Intake on Serum Lipids and Glycemic Control in NIDDM: A randomized controlled study , 1997, Diabetes Care.

[50]  G. Davey Smith,et al.  Non‐communicable diseases in low‐ and middle‐income countries: context, determinants and health policy , 2008, Tropical medicine & international health : TM & IH.

[51]  B. Peterson,et al.  Nurse Case Management To Improve Glycemic Control in Diabetic Patients in a Health Maintenance Organization , 1998, Annals of Internal Medicine.

[52]  M. Mckee,et al.  Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries , 2010, The Lancet.

[53]  R. Josse,et al.  A review of the economic evidence for acarbose in the prevention of diabetes and cardiovascular events in individuals with impaired glucose tolerance , 2006, International journal of clinical practice.

[54]  K. Khunti,et al.  Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial , 2008, BMJ : British Medical Journal.

[55]  A. Skene,et al.  Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease , 2007, Diabetes Care.

[56]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[57]  N. Chaturvedi The burden of diabetes and its complications: trends and implications for intervention. , 2007, Diabetes research and clinical practice.

[58]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[59]  M. Marmot,et al.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians , 1991, The Lancet.

[60]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[61]  W. Srisuphan,et al.  Effects of a diabetes self-management program on glycemic control, coronary heart disease risk, and quality of life among Thai patients with type 2 diabetes. , 2007, Nursing & health sciences.

[62]  Hee-Seung Kim,et al.  A randomized controlled trial of a nurse short-message service by cellular phone for people with diabetes. , 2007, International journal of nursing studies.